Rosalind Advisors »

Replimune Group shares owned by Rosalind Advisors

Quarter-by-quarter ownership of Replimune Group shares owned by Rosalind Advisors from 13F filings

Historical chart of Rosalind Advisors investment in Replimune Group

Tip: Access up to 7 years of quarterly data

All positions including Replimune Group held by Rosalind Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Replimune Group by Rosalind Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $0 265k 0.00

More positions owned by Rosalind Advisors

Delcath Systems Com New (DCTH)
Savara (SVRA)
Fennec Pharmaceuticals (FENC)
Xeris Pharmaceuticals (XERS)
Miragen Therapeutics (VRDN)
Mediwound Shs New (MDWD)
Verastem Com New (VSTM)
Replimune Group (REPL)
Atyr Pharma (ATYR)
Cybin Com New (HELP)
Eyepoint Pharmaceuticals Com New (EYPT)
Cg Oncology (CGON)
Cytokinetics Com New (CYTK)
X4 Pharmaceuticals Com New (XFOR)
Mind Medicine Mindmed Com New (MNMD)

View all positions for Rosalind Advisors

Top funds holding Replimune Group

Rosalind Advisors
Simplex Trading
Hrt Financial
Group One Trading

View all funds holding Replimune Group